PRAZOSIN HYDROCHLORIDE
Generic: PRAZOSIN HYDROCHLORIDE
PRAZOSIN HYDROCHLORIDE is FDA application NDA017442, sponsored by PFIZER. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.
Recalls
cGMP deviation: detection of Nitrosamine Drug Substance-Related Impurities, N-nitroso-prazosin impur
CGMP Deviations-Test results for N-nitroso Prazosin impurity C that are above the Carcinogenic Poten
cGMP deviation: detection of Nitrosamine Drug Substance-Related Impurities, N-nitroso-prazosin impur
CGMP Deviations-Test results for N-nitroso Prazosin impurity C that are above the Carcinogenic Poten
Failed Impurities/Degradation Specification: presence of N-nitroso Prazosin impurity C above the Car
Failed Impurities/Degradation Specification: presence of N-nitroso Prazosin impurity C above the Car
cGMP deviation: detection of Nitrosamine Drug Substance-Related Impurities, N-nitroso-prazosin impur
Failed Impurities/Degradation Specification: presence of N-nitroso Prazosin impurity C above the Car
cGMP deviations: Temperature abuse
CGMP Deviations-Test results for N-nitroso Prazosin impurity C that are above the Carcinogenic Poten